The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
What's in a name? Renaming ‘NAFLD’ to ‘MAFLD’
Abstract
In medicine, language matters and the words used to name and describe a disease can have a profound impact on patients and their families. Over the last two decades, many criticisms have been voiced about the nomenclature and definition of non‐alcoholic fatty liver disease (NAFLD) in regards not only to the prominent role that alcohol plays in the definition but also on the negative impacts of the nomenclature including trivialization, stigmatization and less consideration of the disease in health policy. Recently, a consensus of international experts proposed that the disease acronym be changed from NAFLD to metabolic (dysfunction) associated fatty liver disease or ‘MAFLD’. This change goes far beyond a mere semantic revision and may be the first step that catalyses the process to better conceptualize the disease for health promotion, patient orientation, case identification, ongoing clinical trials and for health services delivery. Here we review the history of, and definitions of MAFLD in the context of advancing our understanding of the pathogenesis of the disease. We also address the reasons, signals, promises, challenges and the way going forward from the name change from various stakeholder perspectives.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun Wong, V., Dufour, J.-F., Schattenberg, J. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.039 · Cited by 4,472
Self-citationMAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
Eslam, M., Sanyal, A. J., George, J., Sanyal, A., Neuschwander-Tetri, B., Tiribelli, C., Kleiner, D. E., Brunt, E., Bugianesi, E., Yki-Järvinen, H., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.312 · Cited by 3,286
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,042
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander-Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,154
(1978) · DigitalGeorgetown (Georgetown University Library) · Cited by 2,128
Younossi, Z. M., Ratziu, V., Loomba, R., Rinella, M., Anstee, Q. M., Goodman, Z., Bedossa, P., Geier, A., Beckebaum, S., Newsome, P. N., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)33041-7 · Cited by 1,277
Schiff, L., & Schiff, E. R. (1975) · Andalas University Repository (Andalas University) · Cited by 1,142
A position statement on NAFLD/NASH based on the EASL 2009 special conference
Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C., & Marchesini, G. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.008 · Cited by 1,058
Genetics and epigenetics of NAFLD and NASH: Clinical impact
Eslam, M., Valenti, L., & Romeo, S. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.003 · Cited by 971
Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella Pneumoniae
Yuan, J., Chen, C., Cui, J., Lu, J., Yan, C., Wei, X., Zhao, X., Li, N., Li, S., Xue, G., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.018 · Cited by 548
Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission
Sarin, S. K., Kumar, M., Eslam, M., George, J., Al Mahtab, M., Akbar, S. M. F., Jia, J., Tian, Q., Aggarwal, R., Muljono, D. H., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30342-5 · Cited by 525
Wong, V. W., Chan, W., Chitturi, S., Chawla, Y., Dan, Y. Y., Duseja, A., Fan, J., Goh, K., Hamaguchi, M., Hashimoto, E., et al. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13857 · Cited by 506
Non-alcoholic fatty liver disease, obesity and the metabolic syndrome
Dietrich, P., & Hellerbrand, C. (2014) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2014.07.008 · Cited by 457
MacSween's Pathology of the Liver
(2012) · Elsevier eBooks · doi:10.1016/c2009-0-47964-9 · Cited by 420
Update on NAFLD genetics: From new variants to the clinic
Trépo, E., & Valenti, L. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.02.020 · Cited by 393
Dongiovanni, P., Stender, S., Pietrelli, A., Mancina, R. M., Cespiati, A., Petta, S., Pelusi, S., Pingitore, P., Badiali, S., Maggioni, M., et al. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12719 · Cited by 367
Sberna, A. L., Bouillet, B., Rouland, A., Brindisi, M. C., Nguyen, A., Mouillot, T., Duvillard, L., Denimal, D., Loffroy, R., Vergès, B., et al. (2018) · Diabetic Medicine · doi:10.1111/dme.13565 · Cited by 322
Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology
Eslam, M., & George, J. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0212-0 · Cited by 308
Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease
Alexander, M., Loomis, A. K., Fairburn-Beech, J., van der Lei, J., Duarte-Salles, T., Prieto-Alhambra, D., Ansell, D., Pasqua, A., Lapi, F., Rijnbeek, P., et al. (2018) · BMC Medicine · doi:10.1186/s12916-018-1103-x · Cited by 272
Åberg, F., Helenius‐Hietala, J., Puukka, P., Färkkilä, M., & Jula, A. (2018) · Hepatology · doi:10.1002/hep.29631 · Cited by 267
Steatohepatitis in obese children: a cause of chronic liver dysfunction.
Moran, J. R., Ghishan, F. K., Halter, S. A., & Hl, G. (1983) · PubMed · Cited by 241
Ekstedt, M., Franzén, L. E., Holmqvist, M., Bendtsen, P., Mathiesen, U. L., Bodemar, G., Ekstedt, M., Franzén, L. E., Holmqvist, M., Bendtsen, P., et al. (2009) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802555991 · Cited by 208
Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
Romeo, S., Sanyal, A., & Valenti, L. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.12.002 · Cited by 202
Siddiqui, M. S., Harrison, S. A., Abdelmalek, M. F., Anstee, Q. M., Bedossa, P., Castera, L., Dimick‐Santos, L., Friedman, S. L., Greene, K., Kleiner, D. E., et al. (2018) · Hepatology · doi:10.1002/hep.29607 · Cited by 167
A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe
Lazarus, J. V., Ekstedt, M., Marchesini, G., Mullen, J., Novak, K., Pericàs, J. M., Roel, E., Romero-Gómez, M., Ratziu, V., Tacke, F., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.027 · Cited by 167
Stigma and treatment delay in first‐episode psychosis: a grounded theory study
Franz, L., Carter, T., Leiner, A. S., Bergner, E., Thompson, N. J., & Compton, M. T. (2010) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2009.00155.x · Cited by 162
Chang, Y., Cho, Y. K., Kim, Y., Sung, E., Ahn, J., Jung, H., Yun, K. E., Shin, H., & Ryu, S. (2019) · Hepatology · doi:10.1002/hep.30170 · Cited by 162
Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study.
Jepsen, P., Vilstrup, H., Mellemkjær, L., Thulstrup, A. M., Olsen, J. H., Baron, J. A., & Sørensen, H. T. (2003) · PubMed · Cited by 152
Consequences of Perceived Stigma Among Patients with Cirrhosis
Vaughn, V. M., Sherman, C. W., Aronsohn, A. I., & Volk, M. L. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2942-0 · Cited by 131
Toward More Accurate Nomenclature for Fatty Liver Diseases
Eslam, M., Sanyal, A. J., & George, J. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.05.064 · Cited by 125
Risk of Cancer in Patients Hospitalized With Fatty Liver
Sørensen, H. T., Mellemkjær, L., Jepsen, P., Thulstrup, A. M., Baron, J. A., Olsen, J. H., & Vilstrup, H. (2003) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200304000-00015 · Cited by 119
Fatty liver disease caused by High-Alcohol-Producing Klebsiella pneumoniae
Yuan, J., Chen, C., Cui, J., Lu, J., Yan, C., Wei, X., Zhao, X., Li, N., Li, S., Xue, G., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.006 · Cited by 118
Patel, P. J., Banh, X., Horsfall, L. U., Hayward, K. L., Hossain, F., Johnson, T., Stuart, K. A., Brown, N. N., Saad, N., Clouston, A. D., et al. (2017) · Internal Medicine Journal · doi:10.1111/imj.13667 · Cited by 108
Bertot, L. C., Jeffrey, G. P., Wallace, M., MacQuillan, G. C., Garas, G., Ching, H. L., & Adams, L. A. (2017) · Hepatology Communications · doi:10.1002/hep4.1018 · Cited by 102
Fatty infiltration of the liver and the development of cirrhosis in diabetes and chronic alcoholism.
CONNOR, C. L. (1938) · PubMed · Cited by 100
Kwon, H. K., Greenson, J. K., & Conjeevaram, H. S. (2013) · Liver International · doi:10.1111/liv.12230 · Cited by 99
Practice patterns in NAFLD and NASH: real life differs from published guidelines
Rinella, M. E., Lominadze, Z., Loomba, R. S., Charlton, M., Neuschwander‐Tetri, B. A., Caldwell, S. H., Kowdley, K. V., & Harrison, S. A. (2015) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x15611581 · Cited by 98
Should Nonalcoholic Fatty Liver Disease Be Renamed?
Loria, P., Lonardo, A., & Carulli, N. (2005) · Digestive Diseases · doi:10.1159/000084728 · Cited by 85
Long, M. T., Massaro, J. M., Hoffmann, U., Benjamin, E. J., & Naimi, T. S. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.11.022 · Cited by 78
What's in a name? A call to reframe non-communicable diseases
Allen, L. N., & Feigl, A. B. (2017) · The Lancet Global Health · doi:10.1016/s2214-109x(17)30001-3 · Cited by 71
Genetic Insights for Drug Development in NAFLD
Eslam, M., & George, J. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.05.002 · Cited by 68
Associations between renaming schizophrenia and stigma-related outcomes: a systematic review
Yamaguchi, S., Mizuno, M., Ojio, Y., Sawada, U., Matsunaga, A., Ando, S., & Koike, S. (2017) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12510 · Cited by 63
Hepatic fat as clinical outcome and therapeutic target for nonalcoholic fatty liver disease
Pelusi, S., & Valenti, L. V. C. (2018) · Liver International · doi:10.1111/liv.13972 · Cited by 61
Alcohol Use Among Arab Americans: What is the Prevalence?
Arfken, C. L., Arnetz, B. B., Fakhouri, M., Ventimiglia, M., & Jamil, H. J. (2011) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-011-9447-8 · Cited by 59
Hallsworth, K., Avery, L., & Trenell, M. I. (2016) · Current Gastroenterology Reports · doi:10.1007/s11894-016-0485-1 · Cited by 52
Cook, N. S., Nagar, S. H., Jain, A., Balp, M., Mayländer, M., Weiss, O., & Chatterjee, S. (2018) · Advances in Therapy · doi:10.1007/s12325-018-0856-0 · Cited by 46
Obeticholic acid: towards first approval for NASH
Eslam, M., Alvani, R., & Shiha, G. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32963-0 · Cited by 43
Is it time to change NAFLD and NASH nomenclature?
Bellentani, S., & Tiribelli, C. (2017) · The Lancet Gastroenterology and Hepatology · doi:10.1016/s2468-1253(17)30146-2 · Cited by 39
Marjot, T., Sbardella, E., Moolla, A., Hazlehurst, J., Tan, G. D., Ainsworth, M. A., Cobbold, J., & Tomlinson, J. (2017) · Diabetic Medicine · doi:10.1111/dme.13540 · Cited by 39
Manns, M. P., Burra, P., Sargent, J. L., Horton, R. C., & Karlsen, T. H. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31734-3 · Cited by 32
Maruta, T., & Matsumoto, C. (2018) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796018000598 · Cited by 31
Brunt, E. M., Neuschwander‐Tetri, B. A., & Burt, A. D. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3398-8.00006-4 · Cited by 29
Nicht-alkoholische Steatohepatitis - von NAFLD zu MAFLD
Balmer, M. L., & Dufour, J. (2011) · Therapeutische Umschau · doi:10.1024/0040-5930/a000148 · Cited by 27
Egyptian liver library: An indexed database for liver disease evidence in Egypt
Alboraie, M. A. A., Youssef, N. F. A., Sherief, A. F., Afify, S., Wifi, M.-N. A., Omran, D., Hafez, E., Omar, H., Eltabbakh, M. M., Abd‐Ellah, M. F., et al. (2019) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2019.05.004 · Cited by 24
Sogolow, E. D., Lasker, J. N., Sharim, R. R., Weinrieb, R. M., & Sass, D. A. (2010) · Illness Crisis & Loss · doi:10.2190/il.18.3.e · Cited by 19
Karlsen, T. H., & Tacke, F. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.02.001 · Cited by 12
Renaming non-communicable diseases
Zou, G., Decoster, K., McPake, B., & Witter, S. (2017) · The Lancet Global Health · doi:10.1016/s2214-109x(17)30218-8 · Cited by 8
Involvement of doctors in Aum Shinrikyo
Tanimoto, T. E., Ozaki, A., Harada, K. S., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31869-5 · Cited by 5
Cited by
Eslam, M., Sarin, S. K., Wong, V. W.-S., Fan, J.-G., Kawaguchi, T., Ahn, S. H., Zheng, M.-H., Shiha, G., Yilmaz, Y., Gani, R., et al. (2020) · Hepatology International · doi:10.1007/s12072-020-10094-2 · Cited by 833
Comparison of MAFLD and NAFLD diagnostic criteria in real world
Lin, S., Huang, J., Wang, M., Kumar, R., Liu, Y., Liu, S., Wu, Y., Wang, X., & Zhu, Y. (2020) · Liver International · doi:10.1111/liv.14548 · Cited by 516
Kumar, S., Duan, Q., Wu, R., Harris, E. N., & Su, Q. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113869 · Cited by 351
Quantification of liver fat content with CT and MRI: state of the art
Starekova, J., Hernando, D., Pickhardt, P. J., & Reeder, S. B. (2021) · Radiology · doi:10.1148/radiol.2021204288 · Cited by 320
Chan, K. E., Koh, T. J. L., Tang, A. S. P., Quek, J., Yong, J. N., Tay, P., Tan, D. J. H., Lim, W. H., Lin, S. Y., Huang, D., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac321 · Cited by 315
Metadata
- Authors
- Fouad, Y., Waked, I., Bollipo, S., Gomaa, A., Ajlouni, Y., & Attia, D.
- Venue
- Liver International
- Publisher
- Wiley
- Published
- 2020-04-28
- Volume
- 40
- Issue
- 6
- Pages
- 1254-1261
- ISSN
- 0106-9543 (ISSN-L)
- 1478-3223
- 1478-3231
- OpenAlex
- W3016284126
- Cited by
- 295
- References
- 62
- FWCI
- 34.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.